advertisement
11.4 Prostaglandins (24)
Showing records 1 to 24
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins8090 Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients
Liu CJ; Ko YC; Cheng CY; Chiu AW; Chou JC; Hsu WM; Liu JH
Ophthalmology 2002; 109: 2241-2247
8083 Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy
Calissendorff B; Sjoquist B; Hogberg G; Grunge-Lowerud A
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 127-131
8082 One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension
Higginbotham EJ; Schuman JS; Goldberg I; Gross RL; VanDenburgh AM; Chen K; Whitcup SM
Archives of Ophthalmology 2002; 120: 1286-1293
8258 A comparison of the fixed combination of latanoprost and timolol with its individual components
Pfeiffer N
Graefe's Archive for Clinical and Experimental Ophthalmology 2002; 240: 893-899
8076 Effect of simultaneous CGRP and PGF2 on the outflow facility in the rabbit eye
Alajuuma P; Oksala O; Alaranta S; Palkama A; Uusitalo H
Ophthalmic Research 2002; 34: 309-313
8074 Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells
Anthony TL; Lindsey JD; Weinreb RN
Investigative Ophthalmology and Visual Science 2002; 43: 3705-3711
8297 Production of prostaglandin E2 by iridial melanocytes exposed to latanoprost acid, A prostaglandin F2ALP analogue
Bergh K; Wentzel P; Stjernschantz J
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 391-400
8354 (-)-Isoproterenol modulation of maxi-K+ channel in nonpigmented ciliary epithelial cells through a G-protein gated pathway
Bhattacharyya BJ; Lee E; Krupin D; Hockberger P; Krupin T
Current Eye Research 2002; 25: 173-181
8068 Safety of unoprostone isopropyl as mono- or adjunctive therapy in patients with primary open-angle glaucoma or ocular hypertension
De Arruda MPA; Yannoulis NC; Haque RM
Drug Safety 2002; 25: 583-597
8273 A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma
Honrubia EM; Larsson LI; Spiegel D; European Latanoprost Study Group
Acta Ophthalmologica Scandinavica 2002; 80: 635-641
8075 Influence of latanoprost on the corneal epithelial barrier function in glaucoma patients
Ishibashi T; Yokoi N; Ohtsuki M; Mori K; Komuro A; Kinoshita S
Ophthalmologica 2002; 216: 351-354
8255 Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure
Jampel HD; Bacharach J; Sheu WP; Wohl LG; Solish AM; Christie W
American Journal of Ophthalmology 2002; 134: 863-871
8077 Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma
Jui-Ling Liu C; Ko YC; Cheng CY; Chou JC; Hsu WM; Liu JH
British Journal of Ophthalmology 2002; 86: 1236-1239
8073 A cost analysis of the prostaglandin analogs
Mick AB; Gonzalez S; Dunbar MT; McSoley J
Optometry 2002; 73: 614-619
8069 Short-term influence on glaucomatous visual field after switching from topical unoprostone to latanoprost
Otani N; Saitou A; Amemiya T
Japanese Journal of Clinical Ophthalmology 2002; 56: 1029-1032
8072 New treatment paradigm for glaucoma: prostaglandin analogue update
Penna P
Drug Benefit Trends 2002; 14: 25-28,30-32
8267 Ciliochoroidal effusion induced by topical latanoprost in a patient with Sturge-Weber syndrome
Sakai H; Sakima N; Nakamura Y; Hayakawa K; Sawaguchi S
Japanese Journal of Ophthalmology 2002; 46: 553-555
8070 Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels
Spada CS; Nieves AL; Woodward DF
Experimental Eye Research 2002; 75: 155-163
8079 Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma
Sponsel WE; Paris G; Trigo Y; Pena M
American Journal of Ophthalmology 2002; 134: 552-559
8078 An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension
Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG
American Journal of Management Care 2002; 8 S240-248
8265 Quantitative analysis of eyelash lengthening following topical latanoprost therapy
Sugimoto M; Sugimoto M.; Uji Y
Canadian Journal of Ophthalmology 2002; 37: 342-345
8243 A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension
Tsukamoto H; Mishima HK; Kitazawa Y; Araie M; Abe H; Negi A; Glaucoma Study Group
Journal of Glaucoma 2002; 11: 497-501
8071 Travoprost
Waugh J; Jarvis B
Drugs and Aging 2002; 19: 465-471; 472-473
8080 Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation
Yeh PC; Ramanathan S
Journal of Cataract and Refractive Surgery 2002; 28: 1814-1818
